{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:31:24Z","timestamp":1775194284605,"version":"3.50.1"},"reference-count":50,"publisher":"Bentham Science Publishers Ltd.","issue":"1","funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University, Riyadh, Saudi Arabia","doi-asserted-by":"publisher","award":["RSP-2021\/380"],"award-info":[{"award-number":["RSP-2021\/380"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec><jats:title>Introduction:<\/jats:title><jats:p>Multidrug-resistant bacteria are rapidly increasing worldwide, increasing antibiotic resistance. The exploitation, misuse, overuse, and decrease of the therapeutic potential of currently available antibiotics have resulted in the development of resistance against bacteria. As the most common bacterial pathogen in humans, Staphylococcus aureus can cause many adverse health effects. In fighting multidrug-resistant Staphylococcus aureus, scientists have identified an extremely relevant target - SaTMPK. SaTMPK is essential for DNA synthesis, which, in turn, is necessary for the replication and cell division of bacteria.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective:<\/jats:title><jats:p>To perform multi-stage screening using the ZINC database, followed by molecular docking, ADMET profiling, molecular dynamics simulations, and energy calculations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>Based on the similar pharmacophoric characteristics of existing SaTMPK crystal structures, a model of interaction-based pharmacophores was developed. We then performed molecular docking studies on the positive hits obtained from the pharmacophore screening. Compounds that exhibited good molecular interactions within the SaTMPK binding sites were further evaluated using in-silico ADMET profiling.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>In a multi-stage screening campaign, three compounds were shortlisted that exhibited physicochemical characteristics suitable for human administration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>The findings from this study should contribute to in vitro and in vivo studies for clinical applications.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1573406418666220407092638","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T06:06:14Z","timestamp":1649484374000},"page":"75-90","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Structure-Based Discovery of Potent Staphylococcus aureus Thymidylate Kinase Inhibitors by Virtual Screening"],"prefix":"10.2174","volume":"19","author":[{"given":"Zaheer","family":"Ul-Haq","sequence":"first","affiliation":[{"name":"H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi-75270 Karachi, Pakistan"},{"name":"Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi-75270, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bakhtawer","family":"Qureshi","sequence":"additional","affiliation":[{"name":"H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi-75270 Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3440-317X","authenticated-orcid":true,"given":"Ruqaiya","family":"Khalil","sequence":"additional","affiliation":[{"name":"Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi-75270, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Saeed","sequence":"additional","affiliation":[{"name":"Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi-75270, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Nur-e-Alam","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O.Box. 2457, Riyadh 11451, Kingdom of Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarfaraz","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O.Box. 2457, Riyadh 11451, Kingdom of Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"S269","DOI":"10.1086\/430788","volume":"41","author":"Weber J.T.","year":"2005","unstructured":"Weber J.T.; Community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2005,41(s4)(Suppl. 4),S269-S272","journal-title":"Clin Infect Dis"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1128\/CMR.00081-09","volume":"23","author":"David M.Z.","year":"2010","unstructured":"David M.Z.; Daum R.S.; Community-associated methicillin-resistant Staphylococcus aureus: Epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010,23(3),616-687","journal-title":"Clin Microbiol Rev"},{"key":"ref=3","first-page":"86","volume":"2","author":"Raygada J.L.","year":"2009","unstructured":"Raygada J.L.; Levine D.P.; Methicillin-resistant staphylococcus aureus: A growing risk in the hospital and in the community. Am Health Drug Benefits 2009,2(2),86-95","journal-title":"Am Health Drug Benefits"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1093\/jac\/dkm309","volume":"60","author":"Kim E.S.","year":"2007","unstructured":"Kim E.S.; Song J.S.; Lee H.J.; Choe P.G.; Park K.H.; Cho J.H.; Park W.B.; Kim S-H.; Bang J-H.; Kim D-M.; Park K.U.; Shin S.; Lee M.S.; Choi H.J.; Kim N.J.; Kim E-C.; Oh M-D.; Kim H.B.; Choe K.W.; A survey of community-associated methicillin-resistant Staphylococcus aureus in Korea. J Antimicrob Chemother 2007,60(5),1108-1114","journal-title":"J Antimicrob Chemother"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1099\/jmm.0.000635","volume":"66","author":"Garcia A.","year":"2017","unstructured":"Garcia A.; Delorme T.; Nasr P.; Patient age as a factor of antibiotic resistance in methicillin-resistant Staphylococcus aureus. J Med Microbiol 2017,66(12),1782-1789","journal-title":"J Med Microbiol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4103\/0974-777X.157245","volume":"7","author":"Kaur D.C.","year":"2015","unstructured":"Kaur D.C.; Chate S.S.; Study of antibiotic resistance pattern in methicillin resistant Staphylococcus aureus with special reference to newer antibiotic. J Glob Infect Dis 2015,7(2),78-84","journal-title":"J Glob Infect Dis"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3390\/toxins13100677","volume":"13","author":"Ahmad-Mansour N.","year":"2021","unstructured":"Ahmad-Mansour N.; Loubet P.; Pouget C.; Dunyach-Remy C.; Sotto A.; Lavigne J-P.; Molle V.; Staphylococcus aureus toxins: an update on their pathogenic properties and potential treatments. Toxins (Basel) 2021,13(10),677","journal-title":"Toxins (Basel)"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"103252","DOI":"10.1016\/j.bioorg.2019.103252","volume":"92","author":"Gatadi S.","year":"2019","unstructured":"Gatadi S.; Madhavi Y.V.; Chopra S.; Nanduri S.; Promising antibacterial agents against multidrug resistant Staphylococcus aureus. Bioorg Chem 2019,92,103252","journal-title":"Bioorg Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/nass\/nrp142","volume":"53","author":"Kandeel M.","year":"2009","unstructured":"Kandeel M.; Kato A.; Kitamura Y.; Kitade Y.; Thymidylate kinase: The lost chemotherapeutic target. Nucleic Acids Symp Ser 2009,53(1),283-284","journal-title":"Nucleic Acids Symp Ser"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1110\/ps.052002406","volume":"15","author":"Kotaka M.","year":"2006","unstructured":"Kotaka M.; Dhaliwal B.; Ren J.; Nichols C.E.; Angell R.; Lockyer M.; Hawkins A.R.; Stammers D.K.; Structures of S. aureus thymidylate kinase reveal an atypical active site configuration and an intermediate conformational state upon substrate binding. Protein Sci 2006,15(4),774-784","journal-title":"Protein Sci"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.2174\/0929867311320100006","volume":"20","author":"Cui Q.","year":"2013","unstructured":"Cui Q.; Shin W.S.; Luo Y.; Tian J.; Cui H.; Yin D.; Thymidylate kinase: An old topic brings new perspectives. Curr Med Chem 2013,20(10),1286-1305","journal-title":"Curr Med Chem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.2174\/1381612826666200403114152","volume":"26","author":"Gul S.","year":"2020","unstructured":"Gul S.; Khalil R.; Ul-Haq Z.; Mubarak M.S.; Computational overview of mycobacterial thymidine monophosphate kinase. Curr Pharm Des 2020,26(15),1676-1681","journal-title":"Curr Pharm Des"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1021\/jm500463c","volume":"57","author":"Kawatkar S.P.","year":"2014","unstructured":"Kawatkar S.P.; Keating T.A.; Olivier N.B.; Breen J.N.; Green O.M.; Guler S.Y.; Hentemann M.F.; Loch J.T.; McKenzie A.R.; Newman J.V.; Otterson L.G.; Mart&#xED;nez-Botella G.; Antibacterial inhibitors of Gram-positive thymidylate kinase: Structure-activity relationships and chiral preference of a new hydrophobic binding region. J Med Chem 2014,57(11),4584-4597","journal-title":"J Med Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bmcl.2012.10.128","volume":"23","author":"Mart&#xED;nez-Botella G.","year":"2013","unstructured":"Mart&#xED;nez-Botella G.; Loch J.T.; Green O.M.; Kawatkar S.P.; Olivier N.B.; Boriack-Sjodin P.A.; Keating T.A.; Sulfonylpiperidines as novel, antibacterial inhibitors of Gram-positive thymidylate kinase (TMK). Bioorg Med Chem Lett 2013,23(1),169-173","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.bioorg.2018.08.021","volume":"81","author":"Zhu K.","year":"2018","unstructured":"Zhu K.; Tao H.; Song J.-L.; Jin L.; Zhang Y.; Liu J.; Chen Z.; Jiang C.-S.; Luo C.; Zhang H.; Identification of 5-benzylidene-2-phenylthiazolones as potent PRMT5 inhibitors by virtual screening, structural optimization and biological evaluations. Bioorg Chem 2018,81,289-298","journal-title":"Bioorg Chem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1021\/ci400481p","volume":"53","author":"Xu L.","year":"2013","unstructured":"Xu L.; Zhou S.; Yu K.; Gao B.; Jiang H.; Zhen X.; Fu W.; Molecular modeling of the 3D structure of 5-HT(1A)R: Discovery of novel 5-HT(1A)R agonists via dynamic pharmacophore-based virtual screening. J Chem Inf Model 2013,53(12),3202-3211","journal-title":"J Chem Inf Model"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1021\/acs.jcim.6b00714","volume":"57","author":"Huang S.","year":"2017","unstructured":"Huang S.; Song C.; Wang X.; Zhang G.; Wang Y.; Jiang X.; Sun Q.; Huang L.; Xiang R.; Hu Y.; Li L.; Yang S.; Discovery of new SIRT2 inhibitors by utilizing a consensus docking\/scoring strategy and structure-activity relationship analysis. J Chem Inf Model 2017,57(4),669-679","journal-title":"J Chem Inf Model"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1007\/s12272-015-0640-5","volume":"38","author":"Macalino S.J.Y.","year":"2015","unstructured":"Macalino S.J.Y.; Gosu V.; Hong S.; Choi S.; Role of computer-aided drug design in modern drug discovery. Arch Pharm Res 2015,38(9),1686-1701","journal-title":"Arch Pharm Res"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.2174\/1568026614666140929124445","volume":"14","author":"Lionta E.","year":"2014","unstructured":"Lionta E.; Spyrou G.; Vassilatis D.K.; Cournia Z.; Structure-based virtual screening for drug discovery: Principles, applications and recent advances. Curr Top Med Chem 2014,14(16),1923-1938","journal-title":"Curr Top Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"Berman H.M.","year":"2000","unstructured":"Berman H.M.; Westbrook J.; Feng Z.; Gilliland G.; Bhat T.N.; Weissig H.; Shindyalov I.N.; Bourne P.E.; The protein data bank. Nucleic Acids Res 2000,28(1),235-242","journal-title":"Nucleic Acids Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/prot.22234","volume":"75","author":"Labute P.","year":"2009","unstructured":"Labute P.; Protonate3D: Assignment of ionization states and hydrogen coordinates to macromolecular structures. Proteins 2009,75(1),187-205","journal-title":"Proteins"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1002\/prot.22711","volume":"78","author":"Lindorff-Larsen K.","year":"2010","unstructured":"Lindorff-Larsen K.; Piana S.; Palmo K.; Maragakis P.; Klepeis J.L.; Dror R.O.; Shaw D.E.; Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins 2010,78(8),1950-1958","journal-title":"Proteins"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"Mysinger M.M.","year":"2012","unstructured":"Mysinger M.M.; Carchia M.; Irwin J.J.; Shoichet B.K.; Directory of Useful Decoys, Enhanced (DUD-E): Better ligands and decoys for better benchmarking. J Med Chem 2012,55(14),6582-6594","journal-title":"J Med Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/ci049714+","volume":"45","author":"Irwin J.J.","year":"2005","unstructured":"Irwin J.J.; Shoichet B.K.; ZINC--a free database of commercially available compounds for virtual screening. J Chem Inf Model 2005,45(1),177-182","journal-title":"J Chem Inf Model"},{"key":"ref=25","year":"2012","unstructured":"OEChem, T.K. OpenEye Scientific Software 2012","journal-title":"OpenEye Scientific Software"},{"key":"ref=26","author":"O\u2019Boyle N.M.","year":"2013","unstructured":"O\u2019Boyle N.M.; Banck M.; James C.A.; Morley C.; Vandermeersch T.; Hutchison G.R.; Open Babel; Access and interconvert chemical information 2013","journal-title":"Open Babel; Access and interconvert chemical information"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"O\u2019Boyle N.M.","year":"2011","unstructured":"O\u2019Boyle N.M.; Banck M.; James C.A.; Morley C.; Vandermeersch T.; Hutchison G.R.; Open babel: An open chemical toolbox. J Cheminform 2011,3(1),33","journal-title":"J Cheminform"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.addr.2016.05.007","volume":"101","author":"Benet L.Z.","year":"2016","unstructured":"Benet L.Z.; Hosey C.M.; Ursu O.; Oprea T.I.; BDDCS, the Rule of 5 and drugability. Adv Drug Deliv Rev 2016,101,89-98","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","volume":"1","author":"Lipinski C.A.","year":"2004","unstructured":"Lipinski C.A.; Lead- and drug-like compounds: The rule-of-five revolution. Drug Discov Today Technol 2004,1(4),337-341","journal-title":"Drug Discov Today Technol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"Lipinski C.A.","year":"2001","unstructured":"Lipinski C.A.; Lombardo F.; Dominy B.W.; Feeney P.J.; Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001,46(1-3),3-26","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1021\/ci049885e","volume":"45","author":"Wolber G.","year":"2005","unstructured":"Wolber G.; Langer T.; LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem Inf Model 2005,45(1),160-169","journal-title":"J Chem Inf Model"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1021\/jm049092j","volume":"48","author":"Triballeau N.","year":"2005","unstructured":"Triballeau N.; Acher F.; Brabet I.; Pin J.-P.; Bertrand H.-O.; Virtual screening workflow development guided by the &#x201C;receiver operating characteristic&#x201D; curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. J Med Chem 2005,48(7),2534-2547","journal-title":"J Med Chem"},{"key":"ref=33","author":"Olivier N.B.","year":"2014","unstructured":"Olivier N.B.; Worldwide Protein Data Bank 2014","journal-title":"Worldwide Protein Data Bank"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"Trott O.","year":"2010","unstructured":"Trott O.; Olson A.J.; AutoDock vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010,31(2),455-461","journal-title":"J Comput Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"E1038","DOI":"10.3390\/molecules23051038","volume":"23","author":"Ram&#xED;rez D.","year":"2018","unstructured":"Ram&#xED;rez D.; Caballero J.; Is it reliable to take the molecular docking top scoring position as the best solution without considering available structural data? Molecules 2018,23(5),E1038","journal-title":"Molecules"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1021\/ci500319f","volume":"54","author":"Da C.","year":"2014","unstructured":"Da C.; Kireev D.; Structural protein-ligand interaction fingerprints (SPLIF) for structure-based virtual screening: Method and benchmark study. J Chem Inf Model 2014,54(9),2555-2561","journal-title":"J Chem Inf Model"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s00044-016-1553-7","volume":"25","author":"Liang J-W.","year":"2016","unstructured":"Liang J-W.; Zhang T-J.; Li Z-J.; Chen Z-X.; Yan X-L.; Meng F-H.; Predicting potential antitumor targets of aconitum alkaloids by molecular docking and protein\u2013ligand interaction fingerprint. Med Chem Res 2016,25(6),1115-1124","journal-title":"Med Chem Res"},{"key":"ref=38","year":"2017","unstructured":"Schr&#xF6;dinger Release 2017-1: QikProp Schr&#xF6;dingerAvailable from: 2017","journal-title":"Schr&#xF6;dinger Release 2017-1: QikProp"},{"key":"ref=39","first-page":"4","author":"Anonymous","year":"2018","unstructured":"Anonymous ; Schr&#xF6;dinger release 2018,4","journal-title":"Schr&#xF6;dinger release"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1186\/1471-2105-15-S16-S13","volume":"15","author":"Grover S.","year":"2014","unstructured":"Grover S.; Dhanjal J.K.; Goyal S.; Grover A.; Sundar D.; Computational identification of novel natural inhibitors of glucagon receptor for checking type II diabetes mellitus. BMC Bioinformatics 2014,15(S16)(Suppl. 16),S13","journal-title":"BMC Bioinformatics"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s008940100045","volume":"7","author":"Lindahl E.","year":"2001","unstructured":"Lindahl E.; Hess B.; van der Spoel D.; GROMACS 3.0: A package for molecular simulation and trajectory analysis. Mol Model Ann 2001,7(8),306-317","journal-title":"Mol Model Ann"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1021\/ct700301q","volume":"4","author":"Hess B.","year":"2008","unstructured":"Hess B.; Kutzner C.; van der Spoel D.; Lindahl E.; GROMACS 4:\u2009Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 2008,4(3),435-447","journal-title":"J Chem Theory Comput"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"4026","DOI":"10.1021\/ct200196m","volume":"7","author":"Malde A.K.","year":"2011","unstructured":"Malde A.K.; Zuo L.; Breeze M.; Stroet M.; Poger D.; Nair P.C.; Oostenbrink C.; Mark A.E.; An automated force field topology builder (ATB) and repository: Version 1.0. J Chem Theory Comput 2011,7(12),4026-4037","journal-title":"J Chem Theory Comput"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1063\/1.448118","volume":"81","author":"Berendsen H.J.C.","year":"1984","unstructured":"Berendsen H.J.C.; Postma J.P.M.; van Gunsteren W.F.; DiNola A.; Haak J.R.; Molecular dynamics with coupling to an external bath. J Chem Phys 1984,81(8),3684-3690","journal-title":"J Chem Phys"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"Essmann U.","year":"1995","unstructured":"Essmann U.; Perera L.; Berkowitz M.L.; Darden T.; Lee H.; Pedersen L.G.; A smooth particle mesh Ewald method. J Chem Phys 1995,103(19),8577-8593","journal-title":"J Chem Phys"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"Genheden S.","year":"2015","unstructured":"Genheden S.; Ryde U.; The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov 2015,10(5),449-461","journal-title":"Expert Opin Drug Discov"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1021\/ci500020m","volume":"54","author":"Kumari R.","year":"2014","unstructured":"Kumari R.; Kumar R.; Lynn A.; g_mmpbsa--a GROMACS tool for high-throughput MM-PBSA calculations. J Chem Inf Model Open Source Drug Discovery Consortium2014,54(7),1951-1962","journal-title":"J Chem Inf Model"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","volume":"162","author":"Hughes J.P.","year":"2011","unstructured":"Hughes J.P.; Rees S.; Kalindjian S.B.; Philpott K.L.; Principles of early drug discovery. Br J Pharmacol 2011,162(6),1239-1249","journal-title":"Br J Pharmacol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"19106","DOI":"10.1038\/s41598-021-97945-6","volume":"11","author":"Opo F.A.D.M.","year":"2021","unstructured":"Opo F.A.D.M.; Rahman M.M.; Ahammad F.; Ahmed I.; Bhuiyan M.A.; Asiri A.M.; Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein. Sci Rep 2021,11(1),19106","journal-title":"Sci Rep"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2174\/157340911795677602","volume":"7","author":"Meng X.-Y.","year":"2011","unstructured":"Meng X.-Y.; Zhang H.-X.; Mezei M.; Cui M.; Molecular docking: A powerful approach for structure-based drug discovery. Curr Computeraided Drug Des 2011,7(2),146-157","journal-title":"Curr Computeraided Drug Des"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406418666220407092638","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/203223\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406418666220407092638","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T20:52:21Z","timestamp":1700427141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/203223\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406418666220407092638","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-08-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}